Device Trial Radar · NCT03920358
FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study
Last checked: Nov 20, 2026Latest source record: Jan 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
156
Actual
Start
Apr 10, 2019
Primary completion
Jun 9, 2023
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Microvention-Terumo, Inc.Public (4543.T)
- Sponsor type
- Industry
- First posted
- Apr 18, 2019
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms
Conditions
- Intracranial Aneurysm
Interventions
FRED, FRED Jr and FRED XDevice
Subjects aged ≥ 18 requiring treatment for an unruptured or recanalized intracranial aneurysm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of complete aneurysm occlusion without associated stenosis of the parent artery (> 50%)Time frame: 12 months
- Morbidity RateTime frame: 6 months
- Mortality RateTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Universitätsklinikum Erlangen
Erlangen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.